A patent review of berberine and its derivatives with various pharmacological activities (2016–2020)

References

• Chen QQ, Ren RR, Zhang QQ, et al. Coptis chinensis Franch polysaccharides provide a dynamically regulation on intestinal microenvironment, based on the intestinal flora and mucosal immunity. J Ethnopharmacol. 2021;267:113542.
   PubMed Web of Science ®Google Scholar
• Gaba S, Saini A, Singh G, et al. An insight into the medicinal attributes of berberine derivatives: a Review. Bioorgan Med Chem. 2021(3): 116143
   PubMedGoogle Scholar
• Belwal T, Bisht A, Devkota HP, et al. Phytopharmacology and clinical updates of berberis species against diabetes and other metabolic diseases. Front Pharmacol. 2020;11:41.
   PubMed Web of Science ®Google Scholar
• Li -D-D, Yu P, Xiao W, et al., Berberine: a promising natural isoquinoline alkaloid for the development of hypolipidemic drugs. Curr Top Med Chem. 2020;20(28): 2634–2647.
   PubMed Web of Science ®Google Scholar
• Zhi D, Feng P-F, Sun J-L, et al. The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides. European Journal of Pharmaceutical Sciences. 2015;76:149–155.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Deng H, Li Y, et al., Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity. J Med Chem. 2021;64(1): 768–781.
   PubMed Web of Science ®Google Scholar
• Singh IP, Mahajan S. Berberine and its derivatives: a patent review (2009 – 2012). Expert Opin Ther Pat. 2013;23(2):215–231.
   PubMed Web of Science ®Google Scholar
• Jin Y, Khadka DB, Cho W-J. Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat. 2016;26(2):229–243.
   PubMed Web of Science ®Google Scholar
• Fan DJ, Wu XR, Dong WN, et al. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats. Drug Dev Ind Pharm. 2013;39(9):1447–1456.
   PubMed Web of Science ®Google Scholar
• Chen W, Miao YQ, Fan DJ, et al. Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats. Aaps Pharmscitech. 2011;12(2):705–711.
   PubMed Web of Science ®Google Scholar
• Zhu JX, Tang D, Feng L, et al. Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride. Drug Dev Ind Pharm. 2013;39(3):499–506.
   PubMed Web of Science ®Google Scholar
• Anderberg EK, Lindmark T, Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res. 1993;10(6):857–864.
   PubMed Web of Science ®Google Scholar
• Zhaojie M, Ming Z, Shengnan W, et al. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. Int J Pharmaceut. 2014;467(1–2):50–59.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen Y, Deng J, et al. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO(2): preparation, characterization and in vivo studies. Int J Pharm. 2014;465(1–2):306–316.
   PubMed Web of Science ®Google Scholar
• Ji YH, Cheng Y. Taxol-berberine nanodrug synthesis method and application. CN110251685A; 2019.
   Google Scholar
• Hu HY, Shen HN, Zhou YQ, et al. Antibacterial nanoparticles based on berberine derivatives and rhamnolipids. CN111973571A; 2020.
   Google Scholar
• Parker SN, Li XM, Liu C, et al. Treatment of immunological disease using berberine nanoparticles. US2020276172; 2020.
   Google Scholar
• Narala S, Nyavanandi D, Srinivasan P, et al. Pharmaceutical co-crystals, salts, and co-amorphous systems: a novel opportunity of hot-melt extrusion. J Drug Deliv Sci Tec. 2021:61;102209
   Google Scholar
• Lv Y, Du GH, Cao JZ, et al. Berberine hydrochloride and ibuprofen eutectic substance as well as preparation method, composition and application thereof. CN110041325A; 2019.
   Google Scholar
• Lou BY, Zhang YJ, Huang YL, et al. Emodin-berberine hydrochloride pharmaceutical co-crystal and preparation method thereof. CN108530440A; 2018.
   Google Scholar
• Lou BY, Zhang YJ, Huang YL, et al. Berberine-chrysin pharmaceutical eutectic crystal and preparation method thereof. CN108570046A; 2019.
   Google Scholar
• Hesari A, Ghasemi F, Cicero AFG, et al. Berberine: a potential adjunct for the treatment of gastrointestinal cancers? J Cell Biochem. 2018;119(12):9655–9663.
   PubMed Web of Science ®Google Scholar
• Yao M, Fan X, Yuan B, et al. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement Altern Med. 2019;19(1):216.
   PubMed Web of Science ®Google Scholar
• Qin QP, Wang ZF, Huang XL, et al. Two telomerase-targeting Pt(ii) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells. Dalton Trans. 2019;48(40):15247–15254.
   PubMed Web of Science ®Google Scholar
• Luo Y, Tian G, Zhuang Z, et al. Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. Am J Transl Res. 2019;11(5):2668–2682.
   PubMed Web of Science ®Google Scholar
• Devarajan N, Jayaraman S, Mahendra J, et al., Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytother Res. 2021; 35(6): 3059–3077.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Kitaguchi D, Morinami S, et al. Berberine-induced nucleolar stress response in a human breast cancer cell line. Biochem Biophys Res Commun. 2020;528(1):227–233.
   PubMed Web of Science ®Google Scholar
• Okubo S, Uto T, Goto A, et al. Berberine Induces Apoptotic Cell Death via Activation of Caspase-3 and −8 in HL-60 Human Leukemia Cells: nuclear Localization and Structure–Activity Relationships. Am J Chin Med. 2017;45(7):1497–1511.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee J, You D, et al. Berberine suppresses cell motility through downregulation of TGF-beta1 in triple negative breast cancer cells. Cell Physiol Biochem. 2018;45(2):795–807.
   PubMedGoogle Scholar
• Li DD, Zhang YY, Liu K, et al. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth. Lab Invest. 2017;97(11):1343–1353.
   PubMed Web of Science ®Google Scholar
• Li S. Use of berberine as drug for preventing transformation of inflammatory cancer and/or preventing tumorigenesis. CN109925313A; 2019.
   Google Scholar
• Philogene BJ, Arnason JT, Towers GH, et al. Berberine: a naturally occurring phototoxic alkaloid. J Chem Ecol. 1984;10(1):115–123.
   PubMed Web of Science ®Google Scholar
• Wang MX, Huo LM, Yang HC, et al. An experimental study on the photodynamic activity of berberine in vitro on cancer cells. J Tradit Chin Med. 1986;6(2):125–127.
   PubMedGoogle Scholar
• Liu H-Q, An Y-W, Hu A-Z, et al. Photodynamic therapy enhanced the antitumor effects of berberine on HeLa Cells. Open Chem. 2019;17(1):413–421.
   Web of Science ®Google Scholar
• Wang J, Zhang KF, Ai HR. Application of berberine to preparation of sensibilization medicament for tumor radiotherapy. CN109394759A; 2019.
   Google Scholar
• Yu L, Zhu HR. Applications of 8-malononitrile berberine in preparing antitumor drug sensitizer. CN106924253A; 2017.
   Google Scholar
• Li XG, Ye XL. Application of 8-alkyl berberine salt to preparation of medicine for preventing and treating lung cancer. CN107281180A; 2020.
   Google Scholar
• Orfila L, Rodrı́guez M, Colman T, et al. Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro. J Ethnopharmacol. 2000;71(3):449–456.
   PubMed Web of Science ®Google Scholar
• Qin HL, Wu LQ, Wang B, et al. Berberine-based derivative and preparation method thereof, pharmaceutical composition, and antitumor uses of berberine-based derivative and pharmaceutical composition. CN107417695A; 2017.
   Google Scholar
• Zhu WL, Shi JM, Li B, et al. Applications of seven-membered ring berberine analog and pharmaceutical composition thereof in preparation of drugs for treatment of hematological tumors. CN108498518A; 2018.
   Google Scholar
• Wang Y, Kheir MM, Chai Y, et al. Comprehensive study in the inhibitory effect of berberine on gene transcription, including TATA box. PLoS One. 2011;6(8):e23495.
   PubMed Web of Science ®Google Scholar
• Tan QP, Wang ZF, Huang XL. Novel berberine antineoplastic platinum (II) complex and synthetic method and application thereof. CN110105402A; 2019
   Google Scholar
• Lin J, Jia BZ, Tang JW, et al. Application of berberine ion pair compound to preparation of anti-breast-cancer drug. CN107550906A; 2018.
   Google Scholar
• Banerjee V, Sharda N, Huse J, et al. Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: using the Chou-Talalay combination index method. European Journal of Pharmacology. 2021;897:173919.
   PubMed Web of Science ®Google Scholar
• Yang HY, Shang X, Zhong GQ, et al. Berberine protects human and rat cardiomyocytes from hypoxia/reoxygenation-triggered apoptosis. Am J Transl Res. 2021;13(2):659–671.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Yang ZM, He ZG, et al. Mitoxantrone and berberine composition and application thereof in preparation of anti-tumor drugs. CN112107565A; 2020.
   Google Scholar
• Gharehbolagh SA, Izadi A, Talebi M, et al. New weapons to fight a new enemy: a systematic review of drug combinations against the drug-resistant fungus Candida auris. Mycoses 2021. doi: https://doi.org/10.1111/myc.13277.
   Google Scholar
• Wang Y, Mei JX. Combined medicine containing berberine hydrochloride and PD1-antibody for preventing and/or treating tumor. CN109224071A; 2019.
   Google Scholar
• Wang TK, Xu ST, Li S, et al. Proanthocyanidins should be a candidate in the treatment of cancer, cardiovascular diseases and lipid metabolic disorder. Molecules. 2020;25(24):5971.
   Web of Science ®Google Scholar
• Cok A, Plaisier C, Salie MJ, et al. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie. 2011;93(7):1187–1192.
   PubMed Web of Science ®Google Scholar
• Kim SH, Shin E-J, Kim E-D, et al. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biol Pharm Bull. 2007;30(11):705–711.
   Web of Science ®Google Scholar
• Zhou LB, Yang Y, Wang X, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism. 2007;56(3):405–412.
   PubMed Web of Science ®Google Scholar
• Wei S, Zhang M, Yu Y, et al. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway. PLoS One. 2016;11(3):e0152097.
   PubMed Web of Science ®Google Scholar
• Li -D-D, Yu P, Xu H, et al. Discovery of C-9 modified berberine derivatives as novel lipid-lowering Agents. Chem Pharm Bull. 2021;69(1):59–66.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Deng A-J, Qin H-L. Two new quaternary protoberberine alkaloids from Corydalis yanhusuo. J Asian Nat Prod Res. 2012;14(5):476–481.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Chen A-F, Wu F, et al. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. Bioorgan Med Chem. 2010;18(16):5915–5924.
   PubMed Web of Science ®Google Scholar
• Elango V, Shamma M. A pyrolytic route to the phthalide-isoquinolines. J Org Chem. 1983;48(25):4879–4881.
   Web of Science ®Google Scholar
• Wu GL, Li C, Feng LC, et al. Novel isoquinoline derivatives. WO. 2010;2010/128061.
   Google Scholar
• Su ZR, Chen JN, Li YC, et al. Application of berberine oxide in preparation of medicines for treating metabolic diseases and pharmaceutical composition containing berberine oxide. CN112138007A; 2020.
   Google Scholar
• Wu Y, Hai L, Li WJ, et al. Synthesis of high B-ring berberine and palmatine derivative and application in reducing blood glucose. CN108101902A; 2020.
   Google Scholar
• He Y, Gao YH, Wu ZH, et al. Preparation method and medical application of statin berberine conjugate. CN105566318A; 2016;
   Google Scholar
• Yang L, He Y, Wu ZH. Method for preparing sartans and berberine conjugates and medical application thereof. CN105622602A; 2016.
   Google Scholar
• Gao YH, He Y, Wu ZH, et al. Preparation and medical application of cholic acid berberine conjugate. CN105693805A; 2016.
   Google Scholar
• Gao YH, He Y, Feng BL. Preparation and medical application of diacerein berberine conjugate. CN105693715A; 2016.
   Google Scholar
• Yang L, He Y, Gao YH, et al. Preparation and medical application of glycyrrhizic acid berberine coupling compound. CN105693813A; 2016.
   Google Scholar
• He Y, Gao YH, Feng BL. Preparation method of cinnamic acid type berberine conjugate and medical application. CN105712989A; 2016
   Google Scholar
• Iser JH, Sali A. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. Drugs. 1981;21(2):90–119.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang X, Yin W, et al. Synthesis and hypoglycemic activity of 9- O -(lipophilic group substituted) berberine derivatives. Bioorg Med Chem Lett. 2016;26(19):4799–4803.
   PubMed Web of Science ®Google Scholar
• Li Y-H, Li Y, Yang P, et al. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg Med Chem. 2010;18(17):6422–6428.
   PubMed Web of Science ®Google Scholar
• Jiang WH, Teng QQ, Meng Q, et al. Synthesis method of berberrubine ester substances. CN112062761A; 2020.
   Google Scholar
• He Y, Gao YH, Wu ZH. Preparation method and application of 9-position substituted di-functional-group berberine derivatives. CN106083842A; 2016
   Google Scholar
• Zhang X, Zhao Y, Zhang M, et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One. 2012;7(8):e42529.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao Y, Xu J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep-UK. 2015;5(1):14405.
   PubMedGoogle Scholar
• Feng R, Shou J-W, Zhao Z-X, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep-UK. 2015;5(1):12155.
   PubMedGoogle Scholar
• Hu ZW, Zhang XW, Yu DQ, et al. Application of berberine and stachyose composition to regulation of intestinal flora. CN111821311A; 2020.
   Google Scholar
• Li Z, Zheng J, Zhang N, et al. Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma. J Asthma. 2016;53(10):999–1005.
   PubMed Web of Science ®Google Scholar
• Cui H-S, Hayasaka S, Zheng L-S, et al. Effect of berberine on monocyte chemotactic protein-1 and cytokine-induced neutrophil chemoattractant-1 expression in rat lipopolysaccharide-induced uveitis. Ophthalmic Res. 2007;39(1):32–39.
   PubMed Web of Science ®Google Scholar
• Liu ZG, Han Y. Use of berberine in treatment or prevention of non-infectious ocular surface inflammation. CN111991391A; 2020.
   Google Scholar
• Qin HL, Wu LQ, Li J, et al. Salicylic acid berberine type alkaloid quaternary ammonium salt and application in preparation of medicines. CN111662281A; 2020
   Google Scholar
• Tian B, Tian M, Huang S-M. Advances in phytochemical and modern pharmacological research of Rhizoma Corydalis. Pharm Biol. 2020;58(1):265–275.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Shin D-S, Oh M-N, et al. Inhibition of the bacterial surface protein anchoring transpeptidase sortase by isoquinoline alkaloids. Biosci Biotechnol Biochem. 2004;68(2):421–424.
   PubMed Web of Science ®Google Scholar
• Jamshld F. Berberine derivative having antibacterial activity, and preparation method and application thereof. CN109180673A; 2018.
   Google Scholar
• Iwasa K, Lee DU, Kang SI, et al. Antimicrobial activity of 8-alkyl- and 8-phenyl-substituted berberines and their 12-bromo derivatives. J Nat Prod. 1998;61(9):1150–1153.
   PubMed Web of Science ®Google Scholar
• He H, Li YL, Xiao YP, et al. Application of 8-octyl berberine salt to preparation of medicines for resisting helicobacter pylori infection. CN111686109A; 2020.
   Google Scholar
• Fei J, Gu CM, Liu YJ. Berberine-mediated UHRF1 (Ubiquitin-like, with PHD and RING finger domains 1) gene inhibition and purpose of UHRF1 gene in preparing medicine capable of treating multiple myeloma. CN111363744A; 2020.
   Google Scholar
• Bronner C, Achour M, Arima Y, et al. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Therapeut. 2007;115(3):419–434.
   PubMed Web of Science ®Google Scholar
• Hervouet E, Lalier L, Debien E, et al. Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One. 2010;5(6):e11333.
   PubMed Web of Science ®Google Scholar
• Chang L, Campbell J, Raji IO, et al. Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery. Sci Rep-UK. 2021;11(1):1121.
   PubMed Web of Science ®Google Scholar
• Zhou LB, Chi TY, Ji XF, et al. Medical application of BBR (berberine. CN108295068A; 2018.
   Google Scholar
• Zhu J, Xue ZZ, Xiao L. Purpose of berberine used for preparing drug for preventing and treating chemotherapy-induced peripheral neuropathy. CN108578403A; 2018.
   Google Scholar
• Jiang JD, Wang Y, Pan LB, et al. Application of berberine, coptisine or active metabolites of berberine and coptisine and salts of berberine, coptisine and active metabolites in preparation of drugs for prevention and/or treatment of uric acid nephropathy. CN110731962A; 2020.
   Google Scholar
• Zhang JH, Zhen Z, Su H, et al. Application of berberine and ginsenoside composition in preparation of medicine for preventing and/or treating diabetes with depression. CN111265523A; 2020.
   Google Scholar
• He XH, Ouyang DY, Xu LH, et al. Application of berberine in preparation of medicines for enhancing inflammasome activation. CN106176741A; 2016.
   Google Scholar
• He XH, Ouyang DY, Xu LH, et al. Use of berberine or active metabolite thereof in preparation of drug for preventing and/or treating phenylketonuria. US2020230118; 2020.
   Google Scholar
• Lu PF, Li XQ, Zhu N, et al. Serum uric acid level is correlated with the clinical, pathological progression and prognosis of IgA nephropathy: an observational retrospective pilot-study. Peerj 2020;8:e10130.
   PubMed Web of Science ®Google Scholar
• Lin CM, Lin WY, Wang PL, et al. Therapeutic uses of berberine formulations. US2017354649; 2017.
   Google Scholar
• Chen HT, Fan CZ, Liang M, et al. Use of berberine or derivative thereof in preparing myocardial perfusion imaging agent. US2020330622; 2020.
   Google Scholar
• Leon-Martinez JM, Martinez-Abundis E, Gonzalez-Ortiz M, et al. Effect of berberine plus bezafibrate administration on the lipid profile of patients with mixed dyslipidemia: a pilot clinical trial. J Med Food. 2021;24(2):795–807.
   PubMed Web of Science ®Google Scholar
• Abdi I. The effects of berberine, cinnamon, or fenugreek seeds on glucose and lipid metabolism in prediabetes and diabetes: an assessment of the quality of the clinical trials. Diabetes. 2020;69.
   Web of Science ®Google Scholar
• Zhang LS, Zhang JH, Feng R, et al. Efficacy and safety of berberine alone or combined with statins for the treatment of hyperlipidemia: a systematic review and meta-analysis of randomized controlled clinical trials. Am J Chinese Med. 2019;47(4):751–767.
   PubMed Web of Science ®Google Scholar
• Ren G, Wang YX, Li YH, et al. Structure-activity relationship of berberine derivatives for their glucose-lowering activities. Int J Clin Exp Med. 2017;10(3):5054–5060.
   Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev. 2012; 64: 4–17.
   Web of Science ®Google Scholar
• Xiao DP, Liu ZB, Zhang SS, et al. Berberine derivatives with different pharmacological activities via structural modifications. Mini-Rev Med Chem. 2018;18(17):1424–1441.
   PubMed Web of Science ®Google Scholar
• Guan XS, Jiang L, Cai LH, et al. A new co-crystal of synthetic drug rosiglitazone with natural medicine berberine: preparation, crystal structures, and dissolution. Molecules. 2020;25(18):18.
   Web of Science ®Google Scholar
• Bhowmik D, Kumar GS. Recent advances in nucleic acid binding aspects of berberine analogs and implications for drug design. Mini-Rev Med Chem. 2015;16(2):104–119.
   Web of Science ®Google Scholar
• Gargallo R, Avino A, Eritja R, et al. Study of alkaloid berberine and its interaction with the human telomeric i-motif DNA structure. Spectro Acta A Mol Biomol Spectrosc. 2021;248:119185.
   PubMed Web of Science ®Google Scholar
• Chang W. Non-coding RNAs and Berberine: a new mechanism of its anti-diabetic activities. European Journal of Pharmacology. 2017;795:8–12.
   PubMed Web of Science ®Google Scholar